Sartorius Stedim Biotech Investor Relations Service

Conference Call | First-Quarter Results 2015

Joachim Kreuzburg will discuss the first-quarter 2015 results on Monday, April 20, 2015, at 3.00 p.m. CET.

You may dial into the teleconference starting at 2.50 p.m. CET at the following numbers:

Germany: +49 (0)69 2222 10637
France: +33 (0)1 76 77 22 38
UK: +44 (0)20 3427 1926
USA: +1 646 254 3369

The dial-in code is: 7111358.

Reference Document 2014

Download pdf  (2.6 MB)

News

Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource

Takeover expands SSB’s service portfolio[more]

Date 17.04.2015     Category Sartorius Stedim Biotech

Dynamic First Quarter in 2015 | Forecast Revised Upwards

Aubagne, April 14, 2015 – Sartorius Stedim Biotech, a leading supplier for the biopharmaceutical industry, today pre-announced results for the first quarter 2015. Based on preliminary figures sales...[more]

Date 14.04.2015     Category Sartorius Stedim Biotech

Sartorius Stedim Biotech Share (DIM)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
(at)sartorius.com
Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
(at)sartorius.com

Phone: +49 551 308-1668